Modification of the cytosolic regions of GABA transporter GAT1 by calpain

Neurochemistry International

Volumn 55, Issue 5, 2009, Pages 288-294

  Baliova, Martina ^a   Knab, Andrea ^a   Franekova, Veronika ^a   Jursky, Frantisek ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Actin; Calpain; GABA; GAT1; MUPP1; Neurotransmitter; PDZ; Transporters; Tubulin

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; CALPAIN; GAT1 PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; GABAERGIC TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN METABOLISM; RAT; SYNAPTOSOME;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN; CALPAIN; CYTOSOL; DNA PRIMERS; ENZYME ACTIVATION; FEMALE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; PROTEIN BINDING; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

RATTUS;

EID: 67649321900     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.03.012     Document Type: Article

References (59)

1. Aarts M.M., and Tymianski M. Molecular mechanisms underlying specificity of excitotoxic signaling in neurons. Curr. Mol. Med. 4 (2004) 137-147
2. Ackermann F., Zitranski N., Heydecke D., Wilhelm B., Gudermann T., and Boekhoff I. The multi-PDZ domain protein MUPP1 as a lipid raft-associated scaffolding protein controlling the acrosome reaction in mammalian spermatozoa. J. Cell Physiol. 214 (2008) 757-768
3. Baliova M., Betz H., and Jursky F. Calpain-mediated proteolytic cleavage of the neuronal glycine transporter, GlyT2. J. Neurochem. 88 (2004) 227-232
4. Baliova M., and Jursky F. Calpain sensitive regions in the N-terminal cytoplasmic domains of glycine transporters GlyT1A and GlyT1B. Neurochem. Res. 30 (2005) 1093-1100
5. Bezprozvanny I., and Maximov A. Classification of PDZ domains. FEBS Lett. 509 (2001) 457-462
6. Binda F., Lute B.J., Dipace C., Blakely R.D., and Galli A. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current. Neuropharmacology 50 (2006) 354-361
7. Borden L.A. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem. Int. 29 (1996) 335-356
8. Carvelli L., Blakely R.D., and DeFelice L.J. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc. Natl. Acad. Sci. 105 (2008) 14192-14197
9. Corey J.L., Davidson N., Lester H.A., Brecha N., and Quick M.W. Protein kinase C modulates the activity of a cloned gamma-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter. J. Biol. Chem. 269 (1994) 14759-21467
10. Cubelos B., Gimenez C., and Zafra F. The glycine transporter GLYT1 interacts with Sec3, a component of the exocyst complex. Neuropharmacology 49 (2005) 935-944
11. Daemen M.A., Hoogland G., Cijntje J.M., and Spincemaille G.H. Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy. Neurosci. Lett. 444 (2008) 112-115
12. Deken S.L., Beckman M.L., Boos L., and Quick M.W. Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A. Nat. Neurosci. 10 (2000) 998-1003
13. Deken S.L., Wang D., and Quick M.W. Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling. J. Neurosci. 23 (2003) 1563-1568
14. Dodd J.R., and Christie D.L. Selective amino acid substitutions convert the creatine transporter to a gamma-aminobutyric acid transporter. J. Biol. Chem. 282 (2007) 15528-15533
15. Elce J.S., Hegadorn C., Gauthier S., Vince J.W., and Davies P.L. Recombinant calpain II: improved expression system and production of a C105A active site mutant for crystallography. Protein Eng. 8 (1995) 843-848
16. Evans J.S., and Turner M.D. Emerging functions of the calpain superfamily of cysteine proteases in neuroendocrine secretory pathways. J. Neurochem. 103 (2007) 840-859
17. Farhan H., Korkhov V.M., Paulitschke V., Dorostkar M.M., Scholze P., Kudlacek O., Freissmuth M., and Sitte H.H. Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat gamma-aminobutyric acid transporter-1 (GAT1). J. Biol. Chem. 279 (2004) 28553-28563
18. Farhan H., Reiterer V., Korkhov V.M., Schmid J.A., Freissmuth M., and Sitte H.H. Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J. Biol. Chem. 282 (2007) 7679-7689
19. Forsburg S.L., and Sherman D.A. General purpose tagging vectors for fission yeast. Gene 191 (1997) 191-195
20. Foster J.D., Adkins S.D., Lever J.R., and Vaughan R.A. Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J. Neurochem. 105 (2008) 1683-1699
21. Franekova V., Baliova M., and Jursky F. Truncation of human dopamine transporter by protease calpain. Neurochem. Int. 52 (2008) 1436-1441
22. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
23. 2+ in isolated synaptic plasma membrane vesicles. Brain Res. Mol Brain Res. 51 (1997) 106-114
24. Guastella J., Nelson N., Nelson H., Czyzyk L., Keynan S., Miedel M.C., Davidson N., Lester H.A., and Kanner B.I. Cloning and expression of a rat brain GABA transporter. Science 249 (1990) 1303-1306
25. Hu J.H., Zhang J.F., Ma Y.H., Jiang J., Yang N., Li X.B., Yu Chi Z.G., Fei J., and Guo L.H. Impaired reproduction in transgenic mice overexpressing gamma-aminobutyric acid transporter I (GAT1). Cell Res. 14 (2004) 54-59
26. Indarte M., Madura J.D., and Surratt C.K. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template. Proteins 70 (2007) 1033-1046
27. Jemth P., and Gianni S. PDZ domains: folding and binding. Biochemistry 46 (2007) 8701-8708
28. Jolivalt C.G., Lee C.A., Ramos K.M., and Calcutt N.A. Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain 140 (2008) 48-57
29. Jursky F., and Nelson N. Developmental expression of GABA transporters GAT1 and GAT4 suggests involvement in brain maturation. J. Neurochem. 67 (1996) 857-867
30. Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M.E., Galli A., and Javitch J.A. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2 (2004) 0387-0394
31. Kim E., and Sheng M. PDZ domain proteins of synapses. Nat. Rev. Neurosci. 10 (2004) 771-781
32. Kunz S., Niederberger E., Ehnert C., Coste O., Pfenninger A., Kruip J., Wendrich T.M., Schmidtko A., Tegeder I., and Geisslinger G. The calpain inhibitor MDL 28170 prevents inflammation-induced neurofilament light chain breakdown in the spinal cord and reduces thermal hyperalgesia. Pain 110 (2004) 409-418
33. Lee F.J., Pei L., Moszczynska A., Vukusic B., Fletcher P.J., and Liu F. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J. 26 (2007) 2127-2136
34. Liu Q.R., Lopez-Corcuera B., Mandiyan S., Nelson H., and Nelson N. Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain. J. Biol. Chem. 268 (1993) 2106-2112 (Erratum in: J. Biol. Chem. 1993, 268, 9156)
35. Mabjeesh N.J., and Kanner B.I. Neither amino nor carboxyl termini are required for function of the sodium- and chloride-coupled γ-aminobutyric acid transporter from rat brain. J. Biol. Chem. 267 (1992) 2563-2568
36. Magnani F., Tate C.G., Wynne S., Williams C., and Haase J. Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J. Biol. Chem. 279 (2004) 38770-38778
37. Massari S., Vanoni C., Longhi R., Rosa P., and Pietrini G. Protein kinase C-mediated phosphorylation of the BGT1 epithelial gamma-aminobutyric acid transporter regulates its association with LIN7 PDZ proteins: a post-translational mechanism regulating transporter surface density. J. Biol. Chem. 280 (2005) 7388-7397
38. McHugh E.M., Zhu W., Milgram S., and Mager S. The GABA transporter GAT1 and the MAGUK protein Pals1: interaction, uptake modulation, and coexpression in the brain. Mol. Cell Neurosci. 26 (2004) 406-417
39. Miranda M., Dionne K.R., Sorkina T., and Sorkin A. Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol. Biol. Cell 18 (2007) 313-323
40. Nelson N. The family of Na+/Cl- neurotransmitter transporters. J. Neurochem. 71 (1998) 1785-1803
41. Núñez E., Alonso-Torres P., Fornés A., Aragón C., and López-Corcuera B. The neuronal glycine transporter GLYT2 associates with membrane rafts: functional modulation by lipid environment. J. Neurochem. 105 (2008) 2080-2090
42. Quick M.W. Regulating the conducting states of a mammalian serotonin transporter. Neuron 40 (2003) 537-549
43. Quick M.W. The role of SNARE proteins in trafficking and function of neurotransmitter transporters. Handb. Exp. Pharmacol. 175 (2006) 181-196
44. Radian R., Ottersen O.P., Storm-Mathisen J., Castel M., and Kanner B.I. Immunocytochemical localization of the GABA transporter in rat brain. J. Neurosci. 10 (1990) 1319-1330
45. Ravna A.W., Jaronczyk M., and Sylte I. A homology model of SERT based on the LeuT(Aa) template. Bioorg. Med. Chem. Lett. 16 (2006) 5594-5597
46. Ray S.K., and Banik N.L. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 173-189
47. Raynaud F., and Marcilhac A. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J. 273 (2006) 3437-3443
48. Sato K., Betz H., and Schloss P. The recombinant GABA transporter GAT1 is downregulated upon activation of protein kinase C. FEBS Lett. 375 (1995) 99-102
49. Sato K., and Kawashima S. Calpain function in the modulation of signal transduction molecules. Biol. Chem. 382 (2001) 743-751
50. Schousboe A., Sarup A., Larsson O.M., and White H.S. GABA transporters as drug targets for modulation of GABAergic activity. Biochem. Pharmacol. 68 (2004) 1557-1563
51. Sitek B., Poschmann G., Schmidtke K., Ullmer C., Maskri L., Andriske M., Stichel C.C., Zhu X.R., and Luebbert H. Expression of MUPP1 protein in mouse brain. Brain Res. 970 (2003) 178-187
52. Torres G.E., Yao W.D., Mohn A.R., Quan H., Kim K.M., Levey A.I., Staudinger J., and Caron M.G. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30 (2001) 121-134
53. Tomimatsu Y., Idemoto S., Moriguchi S., Watanabe S., and Nakanishi H. Proteases involved in long-term potentiation. Life Sci. 72 (2002) 355-361
54. Tompa P., Buzder-Lantos P., Tantos A., Farkas A., Szilagyi A., Banoczi Z., Hudecz F., and Friedrich P. On the sequential determinants of calpain cleavage. J. Biol. Chem. 279 (2004) 20775-20785
55. Ullmer C., Schmuck K., Figge A., and Lübbert H. Cloning and characterization of MUPP1, a novel PDZ domain protein. FEBS Lett. 424 (1998) 63-68
56. Vandenberg R.J., Shaddick K., and Ju P. Molecular basis for substrate discrimination by glycine transporters. J. Biol. Chem. 282 (2007) 14447-21453
57. Vanderklish P.W., and Bahr B.A. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 81 (2000) 323-339
58. Wu H.Y., and Lynch D.R. Calpain and synaptic function. Mol. Neurobiol. 33 (2006) 215-236
59. Yamashita A., Singh S.K., Kawate T., Jin Y., and Gouaux E. Crystal structure of a bacterial homologue of Na+/Cl- dependent neurotransmitter transporters. Nature 437 (2005) 215-223